Antimicrobial stewardship Flashcards
Define antimicrobial stewardship
Concerned. with the optimal selection, dosage, duration of antimicrobials that results in the best clinical outcome for the treatment and prevention of infection with minimal impact on resistance. It involves promoting and monitoring judicious use of antimicrobials to preserve their effectiveness. Encompasses optimising prescribing practice to reduce resistance and unnecessary prescribing.
Why is this so important?
There is an increase in antimicrobial resistance but a reduction in the amount of new antimicrobials coming to market. Now looking at developing new antimicrobials but also modification of existing.
What is the 20 year vision for AMR?
- reduce need for abs/unintentional use
- optimise use
- innovation, supply, access
What is the UK 5 year action plan 2019-24?
- halve the healthcare associated gram negative bloodstream infections
- reduce the number of specific drug resistant infections by 10%
- reduce the UK AM use by 15%, and 25% reduction in use in the community
- 10% reduction in the use of reserve and watch Abs
What schemes are in place to support the delivery of the action plans set out by the NHS?
NHS improvement schemes to support delivery
- NHS standard contract for acute providers - now includes a target to reduce AB use by 1% from the 2018 baseline
- Commissioning for quality & innovation indicators (CQUINS) –> set targets for CCGs and prescribed specialist services - part of the income is conditional on meeting these targets. It is to improve quality of services and create new improved patterns of care. There are AMR CQUINS e.g. 2019/20 = adherence to guidelines for treating UTIs in the older population
What is the purpose of AMS / motivation?
- Reduce total antibiotic use
- reduce inappropriate ab use
- improve susceptibility profiles of hospital pathogens
- Improvement in clinical markers e.g. length of stay, mortality rates
- Increase appropriate use of abs - selection, dosing, route, duration
Why do we want to increase AMS/susceptibility profiles?
- Want to increase survival as AMR reduces it
- Reduce morbidity as AMR increases it.Resistance leads to inappropriate use of agents that will not be as effective which reduces the health outcomes of patients. It also results in toxicity and adverse effects so want to reduce these
- Costs - reduce costs that AMR causes, reducing inappropriate hospital admissions and length of stays
- Patient safety - the impact of multi-drug resistant pathogens is huge as patients have increased duration of hospital stays, increased mortality, allergies, medication errors. More likely to pick up opportunistic infections in hospital which further increases mortality/morbidity
- increase multidisciplinary team working and open culture
What are the common AMS strategies?
- Formulary restriction
- review and audit, feedback by pharmacist for appropriateness of Rx
- Prior approval
- Education/guidelines
- streamlining/de-escalation
- IV to oral
- Antibiotic cycling
Also strategies such as start smart then focus, target
Who are the core members of the AMS team?
Clinical pharmacist with infectious disease expertise
Clinical microbiologist
and/or infectious. disease physician
Who are other members of the AMS team?
Infection control nurse
Hospital epidemiologist
Non clinical management
IT specialist
What is the effectiveness of AMS
Better adherence to prescribing policies
Reduced antibiotic durations
Reduced resistant infections
What is start smart then focus?
Start: do not start antibiotics if there is no evidence of a bacterial infection.
- use guidelines for prompt effective treatment
- document on drug. chart/notes
- get cultures first
- single dose prophylaxis where appt
Focus: Review every 48hrs and with an action plan. Can stop, switch (IV to oral), change, continue, OPAT.
Document everything
What is target?
Treat antibiotics responsible, guidance, education, tools
For changing prescriber and patient attitudes
What are some benefits of formulary. restrictions?
Cost effecive
Ensures guidelines are followed and appt use of abs - effective and direct control
Improves susceptibility profiles of hosp pathogens
Minimises adverse events/toxicity = safer
What. are the benefits. of de-escalation?
- reduced risk of infection e.g. entry site
- may be able to discharge earlier but need to ensure adherence (thus reduce costs, morbidity)
- More specific/narrower spectrum - reduces resistance, CDI, adverse effects